Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
Journal of the International AIDS Society | April 2018
Viral hepatitis is one of the most significant contributors to the global public health burden. There are an estimated 71 million people with hepatitis C and more than four million people living with both HIV and hepatitis C or B. While action on the hepatitis epidemic has been slower than desired, the introduction of direct-acting antivirals has led the World Health Organization (WHO) to call for a 90% reduction in cases and 65% reduction in mortality by 2030.